Boeing "Strikes" a Deal to Buy Revolutionary Heli-Plane Maker

Boeing "Strikes" a Deal to Buy Revolutionary Heli-Plane Maker
It’s been about a year and a half since we first learned of the Defense Advanced Research Projects Agency’s “LightningStrike Project,” the scary-sounding name attached to an entirely benign story of a new class of aircraft that DARPA wants to build. With LightningStrike, DARPA — the “mad scientist” arm of the U.S. Department of Defense — aims to create an... Read More

Cost Creep Remains American Airlines' Achilles Heel

Cost Creep Remains American Airlines' Achilles Heel
In recent years, United Continental ‘s (NYSE: UAL) perennial margin deficit relative to Delta Air Lines (NYSE: DAL) has become a frequent topic of conversation among airline investors and analysts. By contrast, the growing margin gap between American Airlines (NASDAQ: AAL) and Delta has mostly flown beneath the radar. At an investor day event last month, American Airlines’ management laid... Read More

Better Buy: Exelixis, Inc. vs. Intra-Cellular Therapies Inc.

Better Buy: Exelixis, Inc. vs. Intra-Cellular Therapies Inc.
Biotech investors are always looking for the next big thing. That’s exactly what they found in Exelixis (NASDAQ: EXEL) , which ranked as one of the top biotech stocks of 2016  (and 2015 also). But Exelixis isn’t the little biotech ready to hit the big time anymore. Intra-Cellular Therapies (NASDAQ: ITCI) could be, though. Intra-Cellular Therapies stock has taken investors... Read More

2 Winning Tech IPOs of 2017

2 Winning Tech IPOs of 2017
Around a dozen tech companies have gone public so far this year. Post-IPO  life hasn’t worked out so well for some of them, but two in particular have rewarded early investors with solid share price gains. Roku (NASDAQ: ROKU) , which makes streaming media devices for TVs, went public back in September, and its shares have risen more than 50%... Read More

Cost-Sharing Reductions: What Are They, and Why It Matters That Trump Is Ending Them

Cost-Sharing Reductions: What Are They, and Why It Matters That Trump Is Ending Them
The Affordable Care Act (ACA) was signed into law more than seven years ago, but the fact remains that many Americans still don’t understand Barack Obama’s hallmark healthcare law, or healthcare in general. For instance, a Morning Consult poll released in February of this year found that 35% of respondents were unaware that the ACA and Obamacare, which is what... Read More

3 Growth Stocks for Nest-Egg Building

3 Growth Stocks for Nest-Egg Building
Building a nest egg requires patience and time. It’s also important to invest in stocks with solid long-term growth prospects, since growth stocks have historically delivered market-beating performance as a class. But growth stocks don’t have to be high-risk upstarts trying to change the world — they can also be well-established market leaders in the right industry at the right... Read More